NASDAQ · EVO
Evotec SE financials
$1.64+3.14%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $925.0M | $829.3M | $863.8M | $806.1M | $702.8M |
| Gross profit | $134.0M | $119.5M | $193.5M | $186.7M | $172.3M |
| Gross margin | 14.5% | 14.4% | 22.4% | 23.2% | 24.5% |
| Operating income | -$142.9M | -$203.1M | -$124.1M | -$65.1M | -$36.9M |
| Net income | -$121.5M | -$204.0M | -$92.8M | -$188.4M | $245.1M |
| Net margin | −13.1% | −24.6% | −10.7% | −23.4% | 34.9% |
| Diluted EPS | $-0.68 | $-1.16 | $-0.52 | $-1.06 | $1.48 |
| EBITDA | -$25.5M | -$40.2M | -$15.8M | $24.1M | $43.9M |
| Operating cash flow | -$10.8M | $19.0M | $40.3M | $220.8M | $144.0M |
| Free cash flow | -$95.9M | -$103.3M | -$195.5M | $26.2M | $8.7M |
| Diluted shares | 177.6M | 177.3M | 176.9M | 176.7M | 166.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $491.0M | $318.8M | $564.8M | $445.3M | $790.3M |
| Short-term investments | $67.9M | $94.1M | $117.1M | $337.7M | $179.9M |
| Total debt | $403.6M | $408.7M | $692.2M | $551.1M | $409.6M |
| Total assets | $2.01B | $1.99B | $2.49B | $2.42B | $2.53B |
| Total liabilities | $1.06B | $998.9M | $1.25B | $1.15B | $969.0M |
| Shareholders' equity | $954.7M | $991.2M | $1.24B | $1.27B | $1.56B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology